Ocean Biomedical Total Debt vs. Short Ratio
| OCEA Stock | 0.70 0.01 1.41% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 0.0059 | 0.0062 |
|
|
For Ocean Biomedical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ocean Biomedical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ocean Biomedical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ocean Biomedical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ocean Biomedical over time as well as its relative position and ranking within its peers.
Ocean |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.00) | Return On Assets (6.82) |
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ocean Biomedical Short Ratio vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Ocean Biomedical's current stock value. Our valuation model uses many indicators to compare Ocean Biomedical value to that of its competitors to determine the firm's financial worth. Ocean Biomedical is regarded fourth in total debt category among its peers. It is regarded third in short ratio category among its peers . The ratio of Total Debt to Short Ratio for Ocean Biomedical is about 4,590,152 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ocean Biomedical's earnings, one of the primary drivers of an investment's value.Ocean Total Debt vs. Competition
Ocean Biomedical is regarded fourth in total debt category among its peers. Total debt of Health Care industry is now estimated at about 86.79 Million. Ocean Biomedical retains roughly 12.12 Million in total debt claiming about 14% of equities under Health Care industry.
Ocean Short Ratio vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Ocean Biomedical |
| = | 12.12 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Ocean Biomedical |
| = | 2.64 X |
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Ocean Short Ratio Comparison
Ocean Biomedical is currently under evaluation in short ratio category among its peers.
Ocean Biomedical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Ocean Biomedical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ocean Biomedical will eventually generate negative long term returns. The profitability progress is the general direction of Ocean Biomedical's change in net profit over the period of time. It can combine multiple indicators of Ocean Biomedical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -2.2 M | -2.3 M | |
| Net Loss | -862.6 K | -905.7 K | |
| Income Before Tax | -862.6 K | -905.7 K | |
| Net Loss | -56.1 M | -53.3 M | |
| Net Loss | -114.5 M | -108.7 M | |
| Income Tax Expense | -1.4 M | -1.3 M | |
| Total Other Income Expense Net | 1.8 M | 1.8 M | |
| Net Interest Income | 1.4 M | 1.2 M | |
| Interest Income | 1.4 M | 1.2 M | |
| Change To Netincome | 50.9 M | 45.2 M | |
| Net Income Per Share | 0.02 | 0.02 | |
| Income Quality | 0.08 | 0.08 | |
| Net Loss | (0.53) | (0.56) |
Ocean Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Ocean Biomedical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ocean Biomedical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ocean Biomedical's important profitability drivers and their relationship over time.
Use Ocean Biomedical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ocean Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocean Biomedical will appreciate offsetting losses from the drop in the long position's value.Ocean Biomedical Pair Trading
Ocean Biomedical Pair Trading Analysis
The ability to find closely correlated positions to Ocean Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ocean Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ocean Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ocean Biomedical to buy it.
The correlation of Ocean Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ocean Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ocean Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ocean Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Ocean Biomedical position
In addition to having Ocean Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Semiconductor Thematic Idea Now
Semiconductor
Companies involved in production of semiconductor and semiconductor materials. The Semiconductor theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Semiconductor Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
To fully project Ocean Biomedical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ocean Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ocean Biomedical's income statement, its balance sheet, and the statement of cash flows.